Life Science Pharmaceuticals Primary Care Telehealth 
Health Populi
JULY 10, 2023
That offer covered access to the One Medical on-demand and asynchronous virtual care (telehealth) services via the One Medical app enabling 24/7/365 on-demand video chats with licensed clinicians. In this case, it’s about virtual primary care that’s convenient and relatively inexpensive.
Health Populi
FEBRUARY 27, 2023
.” Molly and I covered a lot of ground here , starting with the key forces shaping and accelerating virtual care across the continuum. We learned this lesson during the pandemic quite clearly — connectivity as a social determinant of health.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Healthcare IT News - Telehealth
JANUARY 20, 2022
He sees three major developments: healthcare will become a digital-first system; decentralization will become a major theme for health and life sciences organizations; and video will be part of every healthcare experience. Traditional care delivery is not working for far too many consumers. Please elaborate.
Healthcare IT News - Telehealth
DECEMBER 16, 2020
” For this report, PwC’s Health Research Institute surveyed 2,511 American consumers, 128 health plan executives, 153 healthcare provider organization executives, and 124 pharmaceutical and life sciences executives in August and September 2020. ” Implications of the changing telehealth landscape.
Lloyd Price
SEPTEMBER 2, 2023
Growth of the life sciences sector: The life sciences sector is expected to continue to grow in 2023, driven by the development of new drugs and therapies, as well as the increasing demand for personalized medicine. The overall outlook for the European HealthTech M&A market in 2023 is positive.
Health Populi
JUNE 30, 2023
We’re living in/through and must plan for these ongoing changes, whether we work in provider organizations, health plans, pharma and life science companies, and to be sure, technology and retail/health organizations.
Healthcare IT Today
JANUARY 8, 2024
It is key for pharmaceutical companies to recognize that efficiency does not override compliance, patient safety or regulatory standards. Jane Reed, Director of Life Sciences at Linguamatics, an IQVIA company Pharmaceutical developers have always prioritized drug safety. Dave Latshaw, CEO at BioPhy 1.
Expert insights. Personalized for you.
130 
Let's personalize your content